Polycyclic compounds as potent alpha2-adrenoceptor antagonists

Details for Australian Patent Application No. 2003216760 (hide)

Owner ORION CORPORATION

Inventors Haapalinna, Antti; Karjalainen, Arto; Jokela, Reija; Din Belle, David; Sallnen, Jukka; Tolvanen, Arto

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003216760

PCT Number PCT/FI03/00255

PCT Pub. Number WO2003/082866

Priority 20020642 03.04.02 FI; 60/369,347 03.04.02 US

Filing date 3 April 2003

Wipo publication date 13 October 2003

International Classifications

C07D 455/00 Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine

A61P 025/14 Drugs for disorders of the nervous system

A61P 025/16 Drugs for disorders of the nervous system

A61P 025/18 Drugs for disorders of the nervous system

A61P 025/22 Drugs for disorders of the nervous system

A61P 025/24 Drugs for disorders of the nervous system

A61P 025/28 Drugs for disorders of the nervous system

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/147 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/14 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/4375

A61P 003/06 Drugs for disorders of the metabolism

A61P 003/10 Drugs for disorders of the metabolism

A61P 009/02 Drugs for disorders of the cardiovascular system

A61P 015/10 Drugs for genital or sexual disorders

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 20020642 03.04.02 FI; 60/369,347 03.04.02 US

20 November 2003 Application Open to Public Inspection

  Published as AU-A-2003216760

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003216761-A NOVEL RIBOZYME AND ITS USE

2003216759-A PHOTOCATALYST CONTAINING TITANIUM OXIDE, THE PRODUCTION METHOD AND USE OF THE SAME